Skip to Main Content Skip to Site Map Skip to Accessibility Statement
Home Formulary 6.0 Endocrine 6.1 Diabetes 6.1.2 Antidiabetic drugs 6.1.2.2 Sulfonylureas

6.1.2.2 Sulfonylureas

ChoiceDrug
Formuary choiceGliclazide tablets 40mg, 80mg

Prescribing Notes

  • Prescribe as per NICE NG28 See also NICE visual summary for blood glucose lowering therapy in adults with type 2 diabetes.
  • Gliclazide modified release tablets should be reserved for patients with demonstrable compliance problems.
  • Patients should be informed that sulfonylureas can cause hypoglycaemia. The risk of hypoglycaemia increases with age.
  • Driving requirements and advice for monitoring of blood glucose in people with type 2 diabetes differ depending on medication and license group. Information may be accessed on the GOV.UK website.
  • Counsel patients on ‘sick day rules’ with sulfonylureas.

Also in this Section